Loading interface...

Amimind 50 MG Tablet

Manufactured byMsn Laboratories Ltd.
ContainsAmisulpride
Description

Amimind 50 MG Tablet is an atypical antipsychotic that is used for the treatment of schizophrenia with positive symptoms like hallucinations, delusions, thought disorders, etc. and/or negative symptoms like emotional and social withdrawal, lack of interest, etc. in adults, including patients characterized by predominant negative symptoms. Schizophrenia is a brain disorder characterized by delusions, hallucinations, and reduced speaking.

Side effects

Major & minor side effects for Amimind 50 MG Tablet

  • Fever
  • Excessive sweating
  • Change in heart rate
  • Severe chest pain
  • Swelling, pain, and redness in the legs
  • Restless legs
  • Twitches in the tongue and face
  • Trembling
  • Excessive salivation
  • Constipation
  • Decreased libido
  • Weight gain
  • Missed menstrual periods
  • Gynecomastia (Growth of breast in males)
  • Agitation and anxiety

Uses of Amimind 50 MG Tablet

What is it prescribed for?

  • Schizophrenia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for the effect of this medicine to show may vary depending upon the symptoms. Some symptoms might show improvement within a day of consumption while other symptoms might take weeks.
  • How long do the effects of this medicine last?
    The effect of this medicine is cumulative and lasts for a long duration of time.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe side effects such as dizziness, difficulty in concentration, impaired judgment, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    This medicine has a moderate potential for abuse and habit forming tendencies were reported in a few cases.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with known allergy to amisulpride or any other inactive ingredients present along with the formulation.

Pheochromocytoma

This medicine is not recommended for use in patients having a tumor of the adrenal glands that causes a life-threatening rise in blood pressure.

Prolactin dependent tumor

This medicine is not recommended for use in patients having breast cancer which is associated with high levels of the hormone prolactin in the body.

Levodopa

This medicine is not recommended for use in patients who are consuming levodopa as the effects of these medicines are exactly the opposite.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

QT prolongation

This medicine should be used with extreme caution in patients with a known history of prolonged QT intervals due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Diabetes mellitus

This medicine should be used with caution in patients with diabetes mellitus because it may alter the blood glucose levels in such patients. Close monitoring of blood glucose levels is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Hypokalemia

This medicine should be used with caution in patients having low potassium levels in the body. It is recommended to initiate treatment with this medicine only after the potassium deficit is corrected. Close monitoring of potassium levels, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Use in elderly population

This medicine should be used with extreme caution in the elderly population due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in children

This medicine is not recommended for use in children below 18 years of age since the safety and efficacy of use are not clinically established.

Seizure disorders

This medicine should be used with caution in patients with seizure disorders or central nervous system abnormalities due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Leukopenia

This medicine is not recommended for use in patients who have a decreased white blood cell count characterized by frequent infections, fever with chills, sore throat, and mouth ulcers.

Suicidal ideation

This medicine may increase the risk of suicidal thoughts in some patients. Patients should be monitored closely for any changes in behavior or mood. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Weight gain

This medicine is likely to cause a gain in weight and hence periodic monitoring is required especially in patients who are obese.

Driving or operating machinery

This medicine may cause drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe side effects such as dizziness, difficulty in concentration, impaired judgment, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Diltiazem

Pregabalin

Tramadol

Amiodarone

Quinidine

Bromocriptine

Ropinirole

Disease interactions

Kidney Disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Tardive Dyskinesia

This medicine should be used with extreme caution in patients with tardive dyskinesia, a condition of involuntary repetitive body movements, since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate patient/caregiver education, close monitoring of the patient's condition, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Neuroleptic Malignant Syndrome (NMS)

This medicine should be used with extreme caution in patients with a known history of a neuroleptic malignant syndrome (NMS) due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Liver Disease

This medicine should be used with extreme caution in patients suffering from mild to moderate liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions

Prolactin test

Report the use of this medicine before undergoing a laboratory test to determine the levels of the hormone prolactin in the body. This medicine can interfere with the test and yield false-positive results.
Take this medicine exactly advised by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking this medicine before completion of the course/without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
This medicine works by inhibiting the action of certain specific neurotransmitters in the brain.
Legal Status

Approved

Unknown

Unknown

Approved

Classification

Category

Atypical antipsychotics

Schedule

Schedule H

[Internet]. Medicines.org.uk. 2020 [cited 3 March 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.548.pdf

[Internet]. Medsafe.govt.nz. 2020 [cited 3 March 2020]. Available from:

https://www.medsafe.govt.nz/Consumers/CMI/s/solian.pdf

Amisulpride - DrugBank [Internet]. Drugbank.ca. 2020 [cited 3 March 2020]. Available from:

https://www.drugbank.ca/drugs/DB06288

Amisulpride [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 3 March 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Amisulpride
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.